Results 151 to 160 of about 3,683 (169)

628: Cellular and tissue distribution of globotriaosylceramide in fabry disease

Journal of Clinical Neuroscience, 2007
Hasan Askari, David Kleiner, Chris Kaneski, Linda Spollen, Raphael Schiffmann   +4 more
openaire   +1 more source

Globotriaosylceramide (Gb3) contributes to LoVo/Dx chemoresistance

2023
openaire   +1 more source

Globotriaosylceramide isoform profiles in human plasma by liquid chromatography–tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2004
Kate Zhang
exaly  

Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells

Molecular Genetics and Metabolism, 2008
Raphaël Schiffmann, David F Moore, Jane M Quirk   +2 more
exaly  

Increased globotriaosylceramide on plasma membranes of synchronized familial dysautonomia cells

Journal of Molecular Neuroscience, 1994
B Boyd
exaly  

The sub-cellular localization globotriaosylceramide in Fabry disease

Virchows Archiv, 2008
openaire   +1 more source

Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry

Molecular Genetics and Metabolism, 2005
Toya Ohashi, Teruo Kitagawa, Bryan Winchester   +2 more
exaly  

Determination of globotriaosylceramide in plasma and urine by mass spectrometry

Clinical Chemistry and Laboratory Medicine, 2010
Heidi Rossmann, Ralf Kruger, Michael Beck   +2 more
exaly  

Globotriaosylceramide inhibits iNKT‐cell activation in a CD1d‐dependent manner

European Journal of Immunology, 2016
Macedo Mf, Lucia Mori, Gennaro De Libero   +2 more
exaly  

Dissociation of globotriaosylceramide and impaired endothelial function in α-galactosidase-A deficient EA.hy926 cells

Molecular Genetics and Metabolism, 2018
Justin Kang, Ferraz Mj, Liming Shu
exaly